DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+28.73%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.68B
AUM Growth
+$2.68B
(+8.7%)
Cap. Flow
-$199M
Cap. Flow
% of AUM
-7.42%
Top 10 Holdings %
Top 10 Hldgs %
42.9%
Holding
149
New
19
Increased
23
Reduced
32
Closed
38
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$79.6M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$40.5M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$35.8M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$28.2M |
| 5 |
AGN
ALLERGAN INC
AGN
|
$24.5M |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$49.4M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$46M |
| 3 |
AbbVie
ABBV
|
$44.3M |
| 4 |
BLUE
bluebird bio
BLUE
|
$37.4M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$30.9M |
Sector Composition
| 1 | Healthcare | 54.5% |
| 2 | Financials | 2.8% |
| 3 | Technology | 0.75% |
| 4 | Industrials | 0% |
